Nucleic Acid World Summit-Transforming Cutting Edge Science into Business

September 09, 2004

Strategic Research Institute, Hyatt Harborside Hotel, Boston, MA October 4-6, 2004 Join us at Strategic Research Institute’s 2nd Annual Nucleic Acid World (NAWS) to hear the latest technologies/applications and recent progress in RNA interference and other oligonucleotide-based therapeutics. The 2.5 day conference and exposition, sponsored by a dozen leading organizations in the nucleic acid field will feature 3 concurrent tracks represented by over 50 presenters. ORGANIZED INTO THREE CONCURRENT TRACKS: TRACK #1: RNAi and Other Oligonucleotides in Drug Discovery: Target Validation & Identification TRACK #2: Nucleic Acid-Based Therapeutics: Pre-Clinical & Clinical Development TRACK #3: Nucleic Acid Related Technologies

Organized by:			Strategic Research Institute
Invited Speakers:			PLENARY KEYNOTES: Discovery & Development of RNAi Therapeutics John Maraganore CEO ALNYLAM PHARMACEUTICALS Harnessing RNA Interference for Therapy Judy Lieberman Senior Investigator and Associate Professor of Pediatrics THE CBR INSTITUTE FOR BIOMEDICAL RESEARCH, HARVARD MEDICAL SCHOOL Genome-Wide RNAi Screening in C.elegans, Drosophilia and Human Cells Christopher Echeverri CEO CENIX BIOSCIENCES Current Progress of Pre-Clinical Development of siRNA Therapeutics Nassim Usman SVP & COO SIRNA THERAPEUTICS, INC.

Deadline for Abstracts:			N/A

Registration:			Discounts Available for early registrants
E-mail:			info@srinstitute.com

events